Ross river fever

Summary

Ross river fever (MONDO:0000344) is a disease and 1 clinical trial. A subtype of Alphavirus infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	Ross river fever
Mondo ID	MONDO:0000344
DOID	DOID:0050518
ICD-10-CM	B33.1
ICD-11	1085418398
SNOMED CT	602001
UMLS	C0919833
MedGen	1673033
GARD	0027522
Is cancer (heuristic)	no

Also known as: Ross River virus caused disease or disorder · Ross River virus disease · Ross River virus disease or disorder · Ross River virus infectious disease

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › viral infectious disease › primary viral infectious disease › Togaviridae infectious disease › Alphavirus infectious disease › Ross river fever

Related subtypes (5): O’nyong’nyong fever, Barmah forest virus disease, Venezuelan equine encephalitis, chikungunya, western equine encephalitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
PHASE1/PHASE2	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT00717834	PHASE1/PHASE2	COMPLETED	Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine